Immunosuppressants Stocks List

Immunosuppressants Stocks Recent News

Date Stock Title
Apr 19 ABBV The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Apr 19 ABBV Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
Apr 19 BIIB What's in Store for Biogen (BIIB) This Earnings Season?
Apr 19 BIIB Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key Metrics
Apr 19 ABBV Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Apr 19 TEVA Alvotech/Teva bring new partner to expand access for Humira biosimilar in U.S.
Apr 19 TEVA Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris
Apr 18 ABBV Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
Apr 18 ABBV AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment
Apr 18 ABBV Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
Apr 18 AUPH Aurinia Pharmaceuticals: Potential For Significant Upside By Year-End 2024
Apr 18 TEVA 3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
Apr 18 BIIB Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
Apr 18 ABBV AbbVie succeeds in late-stage trial for Rinvoq in inflammatory condition
Apr 18 ABBV Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
Apr 18 ABBV AbbVie buyout Cerevel posts late-stage win for Parkinson’s disease drug
Apr 18 ABBV Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
Apr 17 ABBV AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know
Apr 17 BIIB Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth
Apr 17 ABBV CVS favors Humira copycats hurting AbbVie’s market share: Evercore
Immunosuppressants

Immunosuppression is a reduction of the activation or efficacy of the immune system. Some portions of the immune system itself have immunosuppressive effects on other parts of the immune system, and immunosuppression may occur as an adverse reaction to treatment of other conditions.In general, deliberately induced immunosuppression is performed to prevent the body from rejecting an organ transplant. Additionally, it is used for treating graft-versus-host disease after a bone marrow transplant, or for the treatment of auto-immune diseases such as systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, or Crohn's disease. This is typically done using medications, but may involve surgery (splenectomy), plasmapheresis, or radiation. A person who is undergoing immunosuppression, or whose immune system is weak for some other reasons (chemotherapy or HIV), is said to be immunocompromised.

Browse All Tags